Kidney transplantation using expanded criteria deceased donors with terminal acute kidney injury: a single center experience in Korea.
10.4174/astr.2018.95.5.278
- Author:
Kyung Jai KO
1
;
Young Hwa KIM
;
Mi Hyeong KIM
;
Kang Woong JUN
;
Kyung Hye KWON
;
Hyung Sook KIM
;
Sang Dong KIM
;
Sun Cheol PARK
;
Ji Il KIM
;
Sang Seob YUN
;
In Sung MOON
;
Jeong Kye HWANG
Author Information
1. Division of Vascular and Transplant Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea. jjungyong@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Acute kidney injury;
Donor selection [E04.936.537.500];
Kidney transplantation
- MeSH:
Acute Kidney Injury*;
Allografts;
Brain Death;
Delayed Graft Function;
Graft Survival;
Humans;
Incidence;
Kidney Transplantation*;
Kidney*;
Korea*;
Survival Rate;
Tissue Donors*;
Transplants
- From:Annals of Surgical Treatment and Research
2018;95(5):278-285
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: We investigated the clinical outcomes of deceased donor kidney transplantation (KT) using kidneys with terminal acute kidney injury (AKI). METHODS: Between February 2000 and December 2013, we performed 202 deceased donor renal transplants from 159 brain dead donors. According to the expanded criteria donor (ECD) and AKI network criteria, we divided 202 recipients into 4 groups: Group I: Non-AKI & standard criteria donor (SCD) (n = 97); group II: Non-AKI & ECD (n = 15); group III: AKI & SCD (n = 52); and group IV: AKI & ECD (n = 38). RESULTS: The incidence of delayed graft function (DFG) was significantly higher in patients with AKI than it was in the non-AKI group (P = 0.008). There were no significant differences among the 4 groups in graft survival (P = 0.074) or patient survival (P = 0.090). However, the long-term allograft survival rate was significantly lower in group IV than it was in other groups (P = 0.024). CONCLUSION: Allografts from deceased donors with terminal AKI had a higher incidence of DGF than did those from donors without AKI. However, there is no significant difference in graft and patient survival rates among the groups. So, the utilization of renal grafts from ECDs with terminal AKI is a feasible approach to address the critical organ shortage.
